Legal News: Medtronic Infuse

	Medtronic Infuse Off Label Marketing Investigation Closed A federal investigation into Medtronic’s practice of marketing Infuse Bone Graft for off-label surgical use has ended. Continue Reading May 21, 2012 \| Tags: Dangerous Medical Devices, Defective Medical Devices, Medtronic Infuse
	New Medtronic Infuse Worries: Cancer Findings In a study released last November, long-time Medtronic Infuse critic Dr. Eugene Carragee published findings that raised concerns with Infuse’s link to cancer. Continue Reading May 18, 2012 \| Tags: Dangerous Medical Devices, Defective Medical Devices, Medtronic Infuse
	Confidential Witness for Medtronic Refuses to Present Confidential Documents In Minnesota, a federal judge has upheld an order for a former Medtronic employee (Confidential Witness 2) involved in a shareholder lawsuit produce documents related to alleged off-label marketing of Medtronic Infuse Bone Growth. Continue Reading April 3, 2012 \| Tags: Dangerous Medical Devices, Defective Medical Devices, Medtronic Infuse
	Infuse Marketing Prompts More Medtronic Shareholders to Appear in Court More Medtronic shareholders have filed suit against the company as a result of Infuse bone growth marketing, based on allegations that the company’s offices and directors irresponsibly inflated the value of company stock through off-label sales and marketing of Infuse. Continue Reading March 29, 2012 \| Tags: Dangerous Medical Devices, Defective Medical Devices, Medtronic Infuse
	Medtronic Ordered to Submit Safety Data in Infuse Lawsuit In Minnesota, a federal judge has ordered that Medtronic submit documentation regarding Infuse bone growth safety information. Continue Reading March 21, 2012 \| Tags: Dangerous Medical Devices, Defective Medical Devices, Medtronic Infuse
	Senators Question Medtronic Infuse Cover-Up U.S. Senators have launched an investigation into whether researchers who were being paid millions of dollars by Medtronic covered up potential side effects of Medtronic’s Infuse bone growth products. Continue Reading Jan. 6, 2012 \| Tags: Dangerous Medical Devices, Defective Medical Devices, Medtronic Infuse
	Medtronic Infuse Bone Graft Lawsuit A bio-engineered product used in spinal and jaw surgery, Medtronic Infuse Bone Graft has been associated with a higher risk of cancer than was previously thought when patients are treated with a high dose of the controversial protein. Especially when Infuse is used in off-label procedures, patients may be at a higher risk for stomach, thyroid, skin, breast, lung, ovarian, leukemia, laryngeal, prostate, pancreatic, and lymphoma cancers. Another Medtronic product that carries a higher dose of rhBMP-2, Amplify, was rejected for approval by the FDA because of its strong link to cancer. Unfortunately, it is known that rhBMP-2 is used in even higher doses than that found in Amplify for a number of off-label procedures. Continue Reading Dec. 29, 2011 \| Tags: Dangerous Medical Devices, Defective Medical Devices, Medtronic Infuse
	Researchers Withheld Medtronic INFUSE Bone Graft Problems A new report shows that surgeons who received millions of dollars from Medtronic did not report serious side effects and complications experienced by patients receiving the Medtronic Infuse bone graft product. Continue Reading Dec. 14, 2011 \| Tags: Dangerous Medical Devices, Defective Medical Devices, Medtronic Infuse

View All Legal News